Fora Capital, LLC Biocryst Pharmaceuticals Inc Transaction History
Fora Capital, LLC
- $903 Million
- Q1 2025
Shares
2 transactions
Others Institutions Holding BCRX
# of Institutions
292Shares Held
176MCall Options Held
721KPut Options Held
489K-
Vanguard Group Inc Valley Forge, PA21.7MShares$225 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$207 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.93MShares$92.6 Million5.64% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.7MShares$90.2 Million1.06% of portfolio
-
State Street Corp Boston, MA7.81MShares$81 Million0.0% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.93B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...